| abstract |
LHRH antagonist complex selected from the group consisting of cetrorelix, antide, antarelix, azaline, A-75998, ganirelix, and Nal-Glu-antagonist, with polyamino acids selected from the group consisting of polyglutamic acid and polyaspartic acid, with an average molecular weight of 2000 to 20,000 g / mol. A method for preparing an immobilized peptide preparation with stabilized activity of proparental administration of a peptide hormone in the form of said complex and a medicament comprising said complex. |